AGE-1: Effects of Advanced Glycation Endproducts on Satiety and Inflammation

Sponsor
University of Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT01434407
Collaborator
The Ministry of Science, Technology and Innovation, Denmark (Other)
19
1
2
7
2.7

Study Details

Study Description

Brief Summary

The purpose of the meal study is to investigate acute effects on satiety and inflammation of advanced glycation endproducts (AGE) in healthy overweight subjects. The AGE content of the meal is affected by food preparation methods: frying/grilling versus boiling/steaming.

Condition or Disease Intervention/Treatment Phase
  • Other: Dietary meal intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
19 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Crossover Meal Study Investigating Effects of Advanced Glycation Endproducts on Satiety and Inflammation
Study Start Date :
Aug 1, 2011
Actual Primary Completion Date :
Mar 1, 2012
Actual Study Completion Date :
Mar 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low AGE meal

Test meal prepared by boiling/steaming the food

Other: Dietary meal intervention
Test meals with different AGE content made by different cooking methods

Experimental: High AGE meal

Test meal prepared by frying/grilling the food

Other: Dietary meal intervention
Test meals with different AGE content made by different cooking methods

Outcome Measures

Primary Outcome Measures

  1. Appetite sensation [Every 30 min up to 5 hours after test meal]

    Appetite sensation measured by visual analogue scales

  2. Plasma ghrelin [Continuous measurement up to 5 hours after test meal]

  3. Plasma GLP-1 [Continuous measurements up to 5 hours after test meal]

  4. Plasma PYY [Continuous measurements up to 5 hours after test meal]

  5. Plasma insulin [Continuous measurements up to 5 hours after test meal]

  6. Plasma glucose [Continuous measurements up to 5 hours after test meal]

  7. Urine AGE [From 24 hour before to 48 hour after test meal]

Secondary Outcome Measures

  1. Plasma triglycerides [Continuous measurements up to 5 hours after test meal]

  2. Expression of genes related to AGE [Continuous measurements up to 24 hours after test meal]

  3. IL-1 beta [Continuous measurements up to 5 hours after test meal]

  4. IL-6 [Continuous measurements up to 5 hours after test meal]

  5. TNF-alpha [Continuous measurements up to 5 hours after test meal]

  6. CRP [Continuous measurements up to 5 hours after test meal]

  7. VCAM [Continuous measurements up to 5 hours after test meal]

  8. ICAM [Continuous measurements up to 5 hours after test meal]

  9. MIF [Continuous measurements up to 5 hours after test meal]

  10. Plasma AGE [Continuous measurements up to 48 hours after test meal]

  11. Urine isoprostanes [From 24 hour before to 24 hours after test meal]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy males and females between 20 and 50 years old

  • BMI 25-40

  • Waist circumference above 88 cm for women and above 102 cm for men

Exclusion Criteria:
  • Exercise training above 8 hour/week

  • Smoking

  • Pregnant or breast-feeding women

  • Post-menstrual women

  • Regular use of medicine (except contraceptive pills)

  • Previous gastric bypass surgery

  • Donation of blood within the last 3 months

  • Involvement in other clinical trials

  • Allergic to paraaminobenzoic acid

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Human Nutrition, University of Copenhagen Copenhagen Frederiksberg C Denmark 1958

Sponsors and Collaborators

  • University of Copenhagen
  • The Ministry of Science, Technology and Innovation, Denmark

Investigators

  • Principal Investigator: Susanne G Bügel, Department of Human Nutrition, University of Copenhagen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AAstrup, Dr Med Sci, University of Copenhagen
ClinicalTrials.gov Identifier:
NCT01434407
Other Study ID Numbers:
  • M200
First Posted:
Sep 14, 2011
Last Update Posted:
Sep 5, 2012
Last Verified:
Sep 1, 2012
Keywords provided by AAstrup, Dr Med Sci, University of Copenhagen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 5, 2012